Neko Health raises $700 million ahead of US launch

Swedish health-tech firm Neko Health, co-founded by Spotify CEO Daniel Ek, has raised $700 million in a Series C funding round led by Lightspeed Venture Partners. The new capital will fund the company's U.S. expansion, with its first clinic set to open later in 2026. Neko Health provides 60-minute preventative health scans to assess risks for conditions like heart attack, stroke, and diabetes.

Series C funding round

• ▪Stockholm-based Neko Health raised $700 million in a Series C funding round
• ▪Existing investors Atomico, General Catalyst, and Lakestar participated in the funding round
• ▪The funding round was led by U.S. venture capital firm Lightspeed Venture Partners and co-led by O.G. Venture Partners
• ▪New backers included Liberty City Ventures, Positive Sum, and the Michael Dell-backed merchant bank BDT & MSD

US market expansion

• ▪The funding was raised ahead of the launch of Neko Health's first U.S. clinic later in 2026
• ▪Stockholm-based Neko Health raised $700 million in a Series C funding round

Health screening technology

• ▪The health assessment is priced at £299 ($400) in Britain and 2,750 Swedish crowns ($286) in Sweden
• ▪The company's scans assess skin health, blood sugar levels, blood abnormalities, and risk factors for metabolic syndrome, stroke, and heart attack
• ▪Neko Health's clinics offer a 60-minute assessment that captures millions of health data points

Company background

• ▪Neko Health was co-founded in 2018 by Hjalmar Nilsonne and Spotify CEO Daniel Ek
• ▪Neko Health is a technology firm focused on the prevention and early detection of disease